Market Segmentation

• Application: Internal Combustion Engine (ICE) Vehicles, Electric Vehicles (EVs)
• Product: Thermoplastic Polyolefins (TPO) and Thermoplastic Vulcanizate (TPV), Mineral Filled, Glass Reinforced, and Additive Concentrate

Regional Segmentation

• North America: U.S., Canada, and Mexico
• South America: Brazil and Rest-of-South America
• Europe: Germany, France, Italy, Spain, Netherlands, and Rest-of-Europe
• China
• U.K.
• Middle East and Africa: U.A.E., Saudi Arabia, Iran, South Africa, Rest-of-Middle East and Africa
• Asia-Pacific and Japan: Japan, India, South Korea, and Rest-of-Asia-Pacific and Japan

Market Growth Drivers

• Regulatory Push to Increase the Adoption of Lightweight Materials
• Increasing Demand for Long Fiber Polypropylene Compound
• Increasing Demand for PP Compounds in Automotive Interiors
• Demand for Materials That Require Negligible Paint Processing

Market Challenges

• Intense Competition from Other Lightweight Materials
• Stagnant Growth of Automotive Market in Developed Countries
• Increase in Use of Public Transport and Car Pooling

Market Opportunities

• Exploring Further Material Replacement Opportunities
• Surge in Demand for Lightweight Materials in Electric Vehicles
• Blue Ocean Opportunities for Growth in MEA and South America

Key Companies Profiled

LyondellBasell Industries Holdings B.V., Mitsui Chemicals Inc., Kingfa Technology, Borealis AG, Washington Penn Plastic Co. Inc., Sumitomo Chemical Co., Ltd., Japan Polypropylene Corporation, Saudi Basic Industries Corporation (SABIC), Avient Corporation, Hexpol AB (RheTech), Ravago, Hyundai Engineering Plastics, APPL Industries Limited, Rialti S.p.A

How This Report Can Add Value

Market by Product, Analysis, and Forecast: The segment gives a brief overview of the product portfolio of different companies and the market presence of different products existing in the market.

Market by Application, Analysis, and Forecast: The segment gives a brief overview of the market status of different applications of the product and key players offering products in those applications. Internal combustion engine (ICE) vehicles are the major consumers of PP compound as these types of vehicles are majorly produced around the globe.

Key questions answered in the Report

• Which global factors are expected to impact the global PP compound market for automotive industry?
• What is the global PP compound market size for automotive industry in terms of revenue from 2021 to 2031?
• How much revenue is expected to be generated by different types of PP compounds?
• Which PP compound application is expected to be dominant in the forecast period 2021-2031?
• Which companies are the major players in the global PP compound for automotive industry, and what are the key market strategies adopted by them?

Global Polypropylene (PP) Compound Market for Automotive Industry Overview

The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts.

Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry

Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020.

Market Segmentation

Global Polypropylene (PP) Compound Market for Automotive Industry by Application

The consumption of PP compounds in vehicles is beneficial to increase fuel efficiency. PP compounds are used in different automobile parts that are cost-effective for vehicle manufacturing, thereby increasing the profit margin for manufacturers. PP compounds are used in lighting instruments, panels, bumpers, sittings, door handles, interiors, and fuel systems. The application of PP compounds gives performance and safety to vehicles.

Global Polypropylene (PP) Compound Market for Automotive Industry by Product

Thermoplastic Polyolefins (TPO) are used for applications that require high impact strength. TPO is polypropylene compounded with a rubber/elastomer without being vulcanized. Polypropylene compound, which contains vulcanized rubber/elastomer, is termed a thermoplastic vulcanizate (TPV). These have high-elastic strength and are used for coverings and tubes. TPO and TPV are widely used in automotive interiors for parts such as instrument panels, center consoles, and interior trims.

Global Polypropylene (PP) Compound Market for Automotive Industry by Region

APAC is the largest consumer of PP compounds, majorly due to the presence of China, India, Japan, and South Korea. These countries are some of the largest vehicle manufacturers globally, and the region accounts for more than 50% of the vehicle produced around the globe.

Key Market Players and Competition Synopsis

LyondellBasell Industries Holdings B.V., Mitsui Chemicals Inc., Kingfa Technology, Borealis AG, Washington Penn Plastic Co. Inc., Sumitomo Chemical Co., Ltd., Japan Polypropylene Corporation, Saudi Basic Industries Corporation (SABIC), Avient Corporation, Hexpol AB (RheTech), Ravago, Hyundai Engineering Plastics, APPL Industries Limited, Rialti S.p.A

The companies that are profiled in the report have been selected based on a selective pool of players, primarily tier-1 (which holds 50-60% of the market), mid segment players (comprise 30-40% share), and small and emerging companies (holds the balance 10-20% share), based on various factors such as product portfolio, annual revenues, market penetration, research, and development initiatives, along with a domestic and international presence in the PP compound industry.

Plastics Market – A Global and Regional Analysis: Focus on Product Types, Molding Types and Their Applications, and Countries – Analysis and Forecast, 2020-2025

The post PP Compound Market for Automotive Industry – A Global and Regional Analysis: Focus on Product, Application, and Countries – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Market Segmentation

• By Product Type: Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa, Zolgenesma, Tecartus, Liso-Cel, Zyntelego, Others
• By Therapeutic Class: Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology and Other Therapeutic Classes
• By Region: North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain,The Netherlands, Russia, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Singapore, Australia, South Korea and Rest-of-Asia-Pacific (RoAPAC)
• Latin America – Brazil, Mexico, and Rest-of-the-Latin America
• Rest-of-the-World

Growth Drivers

• Increasing Incidences of Cancer and other Chronic Diseases
• Rising Number of Clinical Trials
• Increasing Funding and Investments in Cell and Gene Therapy Market
• Favorable Regulatory Environment and FDA Approvals for Cell and Gene Therapy Products

Market Challenges

• Lack of Reliable Vector Production for Cell and Gene Therapy
• Complex Manufacturing and Distribution Setup
• Tedious Process of Therapeutic Commercialization

Market Opportunities

• Drug Approvals and Strong Pipeline of Cell and Gene Therapies
• Increasing Number of Mergers and Acquisitions within the Cell and Gene Industry

Key Cell and Gene Therapy Companies Profiled

Amgen Inc., bluebird bio, Inc., Castle Creek Pharmaceutical Holdings., Kite Pharma, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Spark Therapeutics, Inc., Vericel Corporation, Dendreon Pharmaceuticals LLC., Human Stem Cells Institute, Kolon TissueGene, Inc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co. Ltd., and Sibiono GeneTech Co. Ltd.

Key Questions Answered in this Report:

• What are the different types of approved cell and gene therapies available in the respective market?
• What are the key development strategies implemented by the key players to stand out in this market?
• What are the various manufacturing considerations within the cell and gene therapy market?
• How have the strategic collaborations among the key players providing a push to product development within the global cell and gene therapy market?
• What are the regulations pertaining to the global cell and gene therapy market in different regions?
• What are the initiatives implemented by different government bodies regulating the development and commercialization of cell and gene therapy products and associated platforms?
• How has COVID-19 impacted the cell and gene therapy market?
• How will the urgency of the pandemic influence the global cell and gene therapy market?
• What are the leading companies dominating the global cell and gene therapy market?
• What is the reimbursement scenario of the products offered in the global cell and gene therapy market?
• Based on the product type, which therapy in the global cell and gene therapy market is anticipated to witness a massive rise in demand in the forecast period?
• How is each segment of the global cell and gene therapy market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2027?

Market Overview

Cell and gene therapy are overlapping fields of biomedical research having similar therapeutic goals, which target DNA or RNA inside or outside the body. Both therapies aim at modifying genetic material for treatment of a disease. Gene therapy uses genetic material, or DNA, to manipulate a patient’s cells for the treatment of an inherited or acquired disease. Cell therapy is the introduction of new cells into a patient’s body to grow, replace or repair damaged tissue to treat a disease. The cell and gene therapies are categorized into several therapeutic class, such as rare diseases, oncology, hematology, cardiovascular, ophthalmology, neurology, and others.

The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25,002.1 million in 2027.

The existing cell and gene therapy market is favored by multiple factors, which include increasing incidences of cancer and other chronic diseases, rising number of clinical trials, increasing funding and investments in the cell and gene therapy market, and favorable regulatory environment and FDA Approvals for cell and gene therapy products.

Within the research report, the market is segmented on the basis of product type (Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa, Zolgenesma, Tecartus, Liso-cel, Zyntelego, Others), therapeutic class type (Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa, Zolgenesma, Tecartus, Liso-cel, Zyntelego, Others), and region (North America, Europe, Asia Pacific, Latin America, and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, and future opportunities, among other analyses, to detail the scope and provide a 360-coverage of the domain.

Competitive Landscape

The global cell and gene therapy market witnessed 14 mergers and acquisitions, 14 product launches and approvals, 13 joint ventures, and nine business expansions. 14 mergers and acquisitions, 14 product launches and approvals, 13 joint ventures, and nine business expansions.

Major players within the cell and gene therapy market are Amgen Inc., bluebird bio, Inc., Castle Creek Pharmaceutical Holdings., Kite Pharma, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Spark Therapeutics, Inc., Vericel Corporation, Dendreon Pharmaceuticals LLC., Human Stem Cells Institute, Kolon TissueGene, Inc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co. Ltd., and Sibiono GeneTech Co. Ltd.

The post Global Cell and Gene Therapy Market: Focus on Product Type, Therapeutic Class, Pipeline, Regional and Country Data (15 Countries) – Analysis and Forecast, 2021-2027 first appeared on CRI Report.